RETRACTED: miR-125a-5p upregulation suppresses the proliferation and induces the cell apoptosis of lung adenocarcinoma by targeting NEDD9 (Retracted article. See vol. 49, pg. 29, 2023)

被引:21
|
作者
Zheng, Hong [1 ]
Wu, Jianbo [2 ]
Shi, Jiachen [3 ]
Lu, Chunya [3 ]
Wang, Yuanyuan [2 ]
Sun, Qianqian [2 ]
Zhang, Guojun [3 ]
Zhao, Guoqiang [2 ]
机构
[1] Henan Univ, Inst Mol Med, Dept Pathophysiol, Med Coll, Kaifeng 475004, Henan, Peoples R China
[2] Zhengzhou Univ, Sch Basic Med Sci, 100 Kexue Rd, Zhengzhou 450001, Henan, Peoples R China
[3] Zhengzhou Univ, Dept Resp Med, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China
关键词
lung adenocarcinoma; miR-125a-5p; proliferation; apoptosis; NEDD9; MICRORNA SIGNATURES; CANCER; INVASION; METASTASIS; EXPRESSION; GROWTH;
D O I
10.3892/or.2017.5812
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) are critical translational regulators that act as oncogenes or tumor-suppressor genes. qRT-PCR assay results showed that the expression levels of miR-125a-5p are lower in lung adenocarcinoma (AD) tissues than expression levels in adjacent non-neoplastic tissues. This relative expression was found to be significantly associated with lymph node metastases. Cell growth, apoptosis, caspase activity and Transwell invasion assay results showed that in two lung adenocarcinoma cell lines transfected with a miR-125a-5p mimic, proliferation and invasion rates were found to be significantly reduced, whereas the apoptosis rate of the miR-125a-5p mimic group was enhanced. Subsequent western blotting and luciferase reporter assays showed that miR-125a-5p is able to bind to putative binding sites within the mRNA 3' untranslated region (UTR) of neural precursor cell expressed, developmentally downregulated 9 (NEDD9). Our findings suggest that miR-125a-5p may serve as a therapeutic agent for lung adenocarcinoma through its major target, NEDD9.
引用
收藏
页码:1790 / 1796
页数:7
相关论文
共 50 条
  • [1] RETRACTION: miR-125a-5p upregulation suppresses the proliferation and induces the cell apoptosis of lung adenocarcinoma by targeting NEDD9 (Retraction of Vol 38, Pg 1790, 2017)
    Zheng, Hong
    Wu, Jianbo
    Shi, Jiachen
    Lu, Chunya
    Wang, Yuanyuan
    Sun, Qianqian
    Zhang, Guojun
    Zhao, Guoqiang
    ONCOLOGY REPORTS, 2023, 49 (02)
  • [2] RETRACTED: miR-424-5p Regulates Hepatoma Cell Proliferation and Apoptosis (Retracted article. See vol. 36, pg. 534, 2021)
    Piao, Lianshu
    Wang, Fei
    Wang, Yanyan
    Yang, Zirong
    Li, Qianwei
    Cui, Lifeng
    Yu, Qinggong
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (03) : 196 - 202
  • [3] RETRACTED: miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2 (Retracted article. See vol. 49, pg. 17, 2023)
    Cao, Huiyan
    Liu, Zhiming
    Wang, Rong
    Zhang, Xiaodong
    Yi, Wenfa
    Nie, Guanyuan
    Yu, Yong
    Wang, Guolu
    Zhu, Mingting
    ONCOLOGY REPORTS, 2017, 37 (01) : 147 - 154
  • [4] RETRACTED: miR-141-3p suppresses proliferation and promotes apoptosis by targeting GLI2 in osteosarcoma cells (Retracted article. See vol. 50, pg. 139, 2023)
    Wang, Nan
    Li, Pengcheng
    Liu, Wei
    Wang, Ningning
    Lu, Zhi
    Feng, Jianzhou
    Zeng, Xiandong
    Yang, Jiujie
    Wang, Yong
    Zhao, Wei
    ONCOLOGY REPORTS, 2018, 39 (02) : 747 - 754
  • [5] RETRACTED: MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK (Retracted article. See vol. 15, pg. 487, 2023)
    Zhang, Wei
    Liao, Kai
    Liu, Dongning
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 8137 - 8147
  • [6] RETRACTED: MiR-502-3P suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SET (Retracted article. See vol. 14, pg. 3177, 2021)
    Jin, Haosheng
    Yu, Min
    Lin, Ye
    Hou, Baohua
    Wu, Zhongshi
    Li, Zhide
    Sun, Jian
    ONCOTARGETS AND THERAPY, 2016, 9 : 3281 - 3289
  • [7] RETRACTED: miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52 (Publication with Expression of Concern. See vol. 13, pg. 6855, 2020) (Retracted article. See vol. 16, pg. 475, 2023)
    Chen, Hong
    Xu, Hong
    Meng, Yu-gang
    Zhang, Yun
    Chen, Jun-ying
    Wei, Xiao-ning
    ONCOTARGETS AND THERAPY, 2016, 9 : 6151 - 6160
  • [8] RETRACTED: miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo (Retracted article. See vol. 49, 2023)
    Lin, Xingyu
    Yang, Zhiguang
    Zhang, Peng
    Shao, Guoguang
    ONCOLOGY REPORTS, 2015, 33 (06) : 3053 - 3060
  • [9] RETRACTED: Inhibition of GPR137 suppresses proliferation of medulloblastoma cells in vitro (Retracted article. See vol. 70, pg. 1557, 2023)
    Wang, Chengfeng
    Liang, Qinchuan
    Chen, Guangming
    Jing, Junjie
    Wang, Shousen
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2015, 62 (06) : 868 - 873
  • [10] RETRACTED: miR-138 suppresses cell proliferation and invasion by inhibiting SOX9 in hepatocellular carcinoma (Retracted article. See vol. 13, pg. 13224, 2021)
    Liu, Yahui
    Zhang, Wei
    Liu, Kai
    Liu, Songyang
    Ji, Bai
    Wang, Yingchao
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (05): : 2159 - 2168